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Generalized Multilevel Functional Regression
Ciprian M. Crainiceanu

Ana-Maria Staicu

Chongzhi Di

Abstract
We introduce Generalized Multilevel Functional Linear Models (GMFLM), a novel statistical framework motivated by and applied to the Sleep Heart Health Study (SHHS), the
largest community cohort study of sleep. The primary goal of SHHS is to study the association between sleep disrupted breathing (SDB) and adverse health effects. An exposure
of primary interest is the sleep electroencephalogram (EEG), which was observed for thousands of individuals at two visits, roughly 5 years apart. This unique study design led to the
development of models where the outcome, e.g. hypertension, is in an exponential family
and the exposure, e.g. sleep EEG, is multilevel functional data. We show that GMFLMs
are, in fact, generalized multilevel mixed effect models. Two consequences of this result are
that: 1) the mixed effects inferential machinery can be used for GMFLM and 2) functional
regression models can be extended naturally to include, for example, additional covariates,
random effects and nonparametric components. We propose and compare two inferential
methods based on the parsimonious decomposition of the functional space.
Some key words: Functional principal components, Smoothing, Sleep EEG.
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Introduction

The methodology described in this paper was motivated by our ongoing studies of the
association of sleep and adverse health outcomes. For example, in the Sleep Heart
Health Study (SHHS) we are interested in studying models where the health outcomes, such as Chronic Heart Disease (CHD) or Hypertension (HTN), are regressed
on sleep electroencephalogram (EEG) data and other covariates. Because sleep-EEG
data is recorded at two visits the exposure has a natural multilevel functional struc1
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ture. SHHS contains the largest collection of sleep EEG data on an epidemiologic
cohort, with more than 6000 subjects at the baseline visit and more than 4000 subjects at visit 2. This is just one example of modern research data that have become
increasingly complex, raising non-traditional modeling and inferential challenges. In
particular, advancements in technology and computation have made recording and
processing of functional data possible. In this context, it has become increasingly
necessary to develop models that describe the association between a functional measurement, such as a magnetic resonance image (MRI) or EEG, and outcomes, such
as adverse health effects. Because functional data is now routinely collected at multiple visits these models have to be extended to incorporate the natural multilevel
structure of the functional data.
An appealing statistical methodology for this type of problems is Functional Regression Analysis, which allows the outcomes or the regressors or both to be functions
instead of scalars. Functional Regression Analysis is currently under intense methodological research [3, 9, 17, 23, 24, 27, 33] and is a particular case of Functional Data
Analysis (FDA) [16, 14, 31, 32, 30]. Two comprehensive monographs that provide a
broad overview of FDA with applications to curve and image analysis are [26, 27].
The fundamental notion of FDA methods is to decompose the space of curves into
principal directions of variation. The main method for achieving this employs Principal Component Analysis (PCA) of the raw data or smoothed curves. PCA provides a
simple recipe for dimensionality reduction by estimating the eigenvectors of the functional covariance operator. Furthermore, PCA estimates the subject-specific features
as the coordinates of subject curves in the basis spanned by the functional principal
components. There has been considerable recent effort to apply FDA to longitudinal
data, e.g., [8, 28, 32, 36]. See [22] for a thorough review. Because longitudinal data
are often multilevel, it might be assumed that this work on longitudinal FDA is mul2
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tilevel. However, this work has assumed that one or more functions are observed only
over a single time course, e.g., height is observed over childhood in growth studies.
Thus, in all current FDA research, the term “longitudinal” represents single-level time
series. FDA was extended to multilevel functional data [7], such as when subject-level
curves are observed at several visits.
In this paper we present several novel methodological developments in the general area of functional regression based on functional PCA. First, we introduce the
multilevel functional exposure to incorporate cases when functional data is observed
at multiple time points. Second, we show that all regression models with functional
predictors can be viewed as mixed effects models with two mixed effects sub-models:
an outcome and an exposure model. This has important methodological and computational implications because the mixed effects inferential machinery can be used
and models can be generalized within a well researched statistical framework. Third,
we introduce a Bayesian inferential framework for the joint analysis of the outcome
and exposure mixed effects models to account for the multi-layered variability and
measurement errors. This method is contrasted with a simpler two-stage method
that uses the predicted values of the random effects from the exposure model in the
outcome model. Fourth, we present theoretical and simulation results that provide
insight into when using a two-stage method is a reasonable alternative to the joint
analysis and when it is expected to fail. This has important practical implications for
researchers who would like to decide what method to use in a particular application.
Fifth, we obtain the best linear unbiased predictors and their associated variability for
the random effects in the functional exposure model. These theoretical results provide
an appealing and computationally tractable platform for two-stage analyses. Sixth,
we show how the mixed effects framework allows straightforward generalizations of
functional regression models to incorporate covariates, random effects, smooth func3
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tions of other covariates, etc. Our methods are an evolutionary development in a
growth area of research that build on and borrow strength from multiple methodological frameworks. Given the range of applications and methodological flexibility
of our methods, we anticipate that they will become one of the standard tools of
research in the area of functional regression.
The paper is organized as follows. Section 2 introduces our methodology for singlelevel functional regression. Section 3 discusses the specific challenges of a Bayesian
analysis of the joint mixed effects model corresponding to functional regression. Section 4 generalizes the methods to account for multilevel functional data exposure.
Section 5 provides extensions of functional regression models. Section 6 provides
simulations. Section 7 describes an application to sleep EEG data from the SHHS.
Section 8 summarizes our conclusions.

2
2.1

Single-level functional regression models
Joint mixed effects models

A particularly useful class of models that describe associations between non-gaussian
outcomes and functional data is the class of generalized functional linear models
(GFLM) [23]. The observed data for the ith subject in a GFLM is [Yi , Z i , {Wi (tim ), tim ∈
[0, 1]}], where Yi is the continuous or discrete outcome, Z i is a vector of covariates, and Wi (tim ) is a random curve in L2 [0, 1] observed at time tim , which is the
mth observation, j = 1, . . . , Mi , for the ith subject, i = 1, . . . , n. We assume that
Wi (t) is a proxy observation of the true underlying functional signal Xi (t) and that
Wi (t) = µ(t) + Xi (t) + i (t), where µ(t) is the population average and i (t) is a mean
zero white noise process with variance σ2 . We also assume that the distribution of
Yi is in the exponential family with linear predictor ηi and dispersion parameter α,
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denoted here by EF(ηi , α). The linear predictor is assumed to have the following form
Z

1

ηi =

Xi (t)β(t)dt + Z ti γ,

(1)

0

where β(·) ∈ L2 [0, 1] is a functional parameter and the main target of inference. Note
that if {ψk (·), k ≥ 1} is an orthonormal basis in L2 [0, 1] then both Xi (·) and β(·) have
P
P
unique representations Xi (t) = k≥1 ξik ψk (t), β(t) = k≥1 βk ψk (t) and equation (1)
can be rewritten as
ηi =

X

ξik βk + Z ti γ.

(2)

k≥1

In model (1) the functional parameter β(t) does not depend on a basis, whereas
the coefficients βk are specific to a particular choice of orthonormal basis in L2 [0, 1].
The coordinate version (2) of model (1) is intuitive because it provides a recipe for
regressing an outcome, Yi , on a function, Xi (t), by regressing it on the coordinates,
ξik , of that function in an orthonormal basis, ψk (·). However, this form of the model
is impractical because it involves an infinite number of regressors. Instead we will use
P
t
the following truncated version ηiK = K
k=1 ξik βk +Z i γ, where K is the truncation lag.
Once ψk (·) and K are fixed, the functional regression model becomes a generalized
linear model (GLM)


 Yi ∼ EF(η K , α);
i
P

K
t
 ηiK =
k=1 ξik βk + Z i γ.

(3)

For reference, we will call equations (3) the outcome model. Note that the outcome
model (3) is not an ordinary GLM because the scores, ξik , k = 1, . . . , K, are indirectly
observed through the random curves Xi (t), i = 1, . . . , n, which, in turn, are indirectly
observed through the proxy functions Wi (t).
From a theoretical perspective, the choice of the orthonormal basis, ψk (·), is not
important. There are an infinite number of bases in L2 [0, 1], but some, including the
5
Hosted by The Berkeley Electronic Press

Fourier, wavelet and Hermite polynomials, are more popular. Each basis tends to
work better in particular applications. For example, the Fourier basis works better
when observed data are mixtures of sinusoidal signals, while polynomial bases work
better when underlying signals are smooth. It is our practical experience that some
bases are good for many applications and no basis is best for all.
In this paper we use Functional Principal Component Analysis (FPCA) [27] to
obtain a basis that captures most of the functional variability of the space spanned
by Xi (t) with its first few dimensions. FPCA is based on the covariance operator
KX (t, s) = Cov{Xi (t), Xi (s)}. Mercer’s theorem (see [15], Chapter 4) provides the
P∞
following convenient spectral decomposition KX (t, s) =
k=1 λk ψk (t)ψk (s), where
λ1 ≥ λ2 ≥ . . . are the ordered eigenvalues and ψk (·) are the associated orthonormal
eigenfunctions of KX (·, ·) in the L2 norm. The Karhunen-Loève (KL) decomposiP∞
tion [18, 21] of the subject level functions is Xi (t) =
k=1 ξik ψk (t) where ξik =
R1
Xi (t)ψk (t)dt are the principal component scores with E(ξik ) = 0, Var(ξik ) = λk
0
and Cov(ξik , ξik0 ) = 0 for every i and k 6= k 0 .
The covariance operator of the observed data, Wi (t), is KW (t, s) = KX (t, s) +
σ2 δt,s , where δt,s = 1 if t = s and 0 otherwise. These equations suggest a natural
solution for estimating the eigenvalues, eigenfunctions and the nugget variance, σ2 .
The first step of the procedure is to estimate the mean function µ(t) using, for example, penalized spline smoothing [29] under the working independence assumption.
For issues on smoothing for dependent data, see discussion in [20]. The second step
is to obtain the method of moment estimates of KW (t, s), denoted by K̂W (t, s). The
third step is to estimate K̂X (t, s) by smoothing K̂W (t, s) for t 6= s, as suggested by
[31, 34]. We propose to use penalized thin plate because bivariate local polynomial
smoothing would be prohibitively slow for the size of our sleep data. The fourth step
is to predict the diagonal elements, K̂X (t, t), and estimate the error variance σ2 as
6
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σ̂ 2 =

R

{ K̂W (t, t) − K̂X (t, t) }dt. The fifth step is to estimate the eigenvalues and

eigenfunctions of K̂X (t, s).
Once the eigenfunctions ψk (·) and a truncation lag K are fixed, the model for
observed functional data can be written as a linear mixed model. Indeed, by construction, ξik are mutually uncorrelated with mean 0 and variance λk . By assuming
a normal shrinkage distribution for scores and errors, the model can be rewritten as


 Wi (t) = PK ξik ψk (t) + i (t);
k=1

 ξik
∼ N(0, λk ); i (t) ∼ N(0, σ2 ).

(4)

For reference, we will call equations (4) the exposure model. A close inspection of
the model will reveal that this is a linear mixed model [19] with the random effects
ξik being the quantities that are used in the outcome model (3). We propose to
jointly estimate the two outcome and exposure mixed effects models (3) and (4). In
Section 2.2 we show that two-stage estimation, that is predicting the random effects
in model (4) and plugging them in the model (3), may lead to misspecified variability
when the outcome, Yi , is normally distributed and biased estimators and misspecified
variability when it is not normally distributed.

2.2

BLUP plug-in versus joint estimation

To better understand the potential problems associated with two-stage estimation we
describe the induced likelihood for the observed data. We introduce the following
notations ξ i = (ξi1 , . . . , ξiK )t and W i = {Wi (ti1 ), . . . , Wi (tiMi )}t , where Mi is the
total number of functional observations for subject i. With a slight abuse of notation
R
[Yi |W i , Z i ] = [Yi , ξ i |W i , Z i ]dξ i , where [·|·] denotes the probability density function
of the conditional distribution. The assumptions in models (3) and (4) imply that

7
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[Yi , ξ i |W i , Z i ] = [Yi |ξ i , Z i ][ξ i |W i ], which, in turn, implies that
Z
[Yi |W i , Z i ] =

[Yi |ξ i , Z i ][ξ i |W i ]dξ i .

(5)

Under normality assumptions it is easy to prove that [ξ i |W i ] = N{m(W i ), Σi }, where
m(W i ) and Σi are the mean and covariance matrix of the conditional distribution
of ξ given the observed functional data and model (4). In section 2.3 we provide the
derivation of m(W i ) and Σi and more insight into their effect on inference.
For most nonlinear models the induced model for observed data (5) does not have
an explicit form. A procedure to avoid this problem is to use a two-stage approach
with the following components: 1) produce predictors of ξ i , say b
ξ i , based on the
exposure model (4); and 2) estimate the parameters of the outcome model (3) by
replacing ξ i with b
ξ i . It is reasonable to use the best linear unbiased predictor (BLUP)
of ξ i , b
ξ i = m(W i ), but other predictors could also be used. For example, Müller and
R1
Stadtmüller [23] used ξbik = 0 Wi (t)ψk (t)dt, which are unbiased predictors of ξik . We
will show that these predictors may lead to biased estimators even in normal linear
models. Moreover, they have higher variance than the BLUPs, m(W i ), because they
do not borrow strength across subjects. This problem is especially serious when the
number of observations per subject is small, but may be negligible when it is large.
A two-stage estimation procedure is an appealing alternative to joint model estimation. In particular, it is intuitive, computationally tractable, and provides unbiased
estimators under the normality assumption. A drawback of the two-stage procedure is
that it ignores the effect of variability of predictors, b
ξ. This may lead to misspecified
variability when the distribution of the outcome is normal and estimation bias and
misspecified variability when it is not. To illustrate these ideas we show the effects
of the two-stage procedure in Normal/identity and a Bernoulli/probit models.

8
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The Normal/identity model. Assume that Yi = ξ ti β + Z ti γ + ei , where β =
(β1 , . . . , βK )t , ei ∼ N (0, σe2 ) and ξ i are mutually independent. It can be shown that
E(Yi |W i , Z i ) = mt (W i )β + Z ti γ and Var(Yi |W i , Z i ) = β t Σi β + σe2 . In Section 2.3
we show that, in typical applications, Σi does not depend on W i or Z i but depends
on the sampling times, tim , for the function W i . In the case when Mi = M and
tim = tm , for all i and m, Σi = Σ and ση2 = β t Σβ + σe2 is still arbitrary because σe2
is arbitrary. In this case the induced model for observed data is equivalent to

Yi = mt (W i )β + Z ti γ + ηi

(6)

where ηi ∼ Normal(0, ση2 ) are mutually independent. Thus, in the balanced case
the two-stage procedure leads to unbiased estimators of the model parameters and
correctly specified variability if and only if ξ i is replaced by m(W i ). However, if the
number of observations per subject, Mi , or the sampling points, tim , vary with the
subject i then Σi is not constant. In this case the maximum likelihood estimators
of β and γ based on model (6) would still be consistent. However, their standard
errors would be incorrect because the homoscedastic model (6) would be used when
the actual variances are heteroscedastic.
The Bernoulli/probit model. Consider the following outcome model Yi |ξ i , Z i ∼
Bernoulli(pi ), where Φ−1 (pi ) = ξ ti β + Z ti γ, and Φ(·) is the cumulative distribution
function of a standard normal distribution. Under the normality assumption of the
distribution of ξ i it follows that the induced model for observed data is


 Yi |W i , Z i ∼ Bernoulli(qi );

 Φ−1 (qi )
= {mt (W i )β + Z ti γ}/(1 + β t Σi β)1/2 .

(7)

Thus, using the two-stage procedure, where ξ i is simply replaced by mt (W i ), leads to
9
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biased estimators with misspecified variability for β and γ. The size of these effects
is controlled by β t Σi β.

2.3

The posterior distribution of scores

In the previous section we showed that a two-stage estimation procedure results in
biased estimators and that the size of the bias is affected, if not determined, by
the covariance matrix, Σi , of the conditional distribution, [ξ i |W i ]. This type of
problem is also encountered in measurement error models, where the analog of the
two stage-stage procedure is referred to as regression calibration [2]. While, in that
context, regression calibration has been criticized for the same reasons we describe
here for two-stage procedures, it remains a fast and robust first order bias correction
strategy that often outperforms more sophisticated methods. Thus, it is reasonable
to ask whether and how much would be gained in the functional regression context
by switching from a two-stage to a joint model analysis. To answer this questions we
take a closer look at the the conditional distribution [ξ i |W i ] and provide a simplified,
but revealing, example at the end of this section. In Section 6 we provide further
insight into the size of the bias and bias correction using both methods.
Under the assumptions in models (3) and (4) the joint distribution of (W ti , ξ ti )t
P
2
is multivariate normal with zero mean. Because var{Wi (t)} = σ2 + K
k=1 λk ψk (t),
P
cov{Wi (t), Wi (s)} = K
k=1 λk ψk (t)ψk (s), var{ξik } = λk and cov{Wi (t), ξik } = λk ψk (t)
it follows that (W ti , ξ ti )t ∼ N(0, Σi ) where


Σi = 

σ2 I Mi

+ Ψi ΛΨi
ΛΨti

t


Ψi Λ 
,
Λ

(8)

I Mi is the Mi dimensional identity matrix, Ψi is the Mi × K dimensional matrix with
the jth row equal to ψ tim = {ψ1 (tim ), . . . , ψK (tim )}, and Λ is the K × K dimensional
10
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diagonal matrix with the diagonal equal to (λ1 , . . . , λK ). It follows that [ξ i |W i ] =
N{m(W i ), Σi }, where


 m(W i ) = ΛΨt (σ 2 I M + Ψi ΛΨt )−1 W i ;
i 
i
i

 Σi

(9)

= Λ − ΛΨti (σ2 I Mi + Ψi ΛΨti )−1 Ψi Λ.

The first equation in (9) provides the recipe for calculating the BLUPs of the
functional scores based on the exposure model (4). A careful inspection of the second equation in (9) reveals important characteristics of Σi . First, Σi ≤ Λ, that is,
Λ − Σi is positive-semidefinite, where Σi and Λ are the conditional and prior covariance matrices of ξ i , respectively. This is a quantification of the natural reduction of
variability after conditioning on observed data. Despite this reduction, Σi is not zero.
Second, the amount of variability described by Σi depends essentially on the prior
covariance, Λ, and the variance, σ2 , of the error process i (t). In particular, when
σ2 approaches infinity, Σi approaches Λ at the rate O(σ−2 ), indicating that large
noise levels will correspond to little or no reduction of variability. In practice, such
extreme cases rarely occur, but a wide spectrum of noise levels might be expected.
Depending on the noise levels, the matrix Σi will be closer to one of the extremes, Λ
or Λ − ΛΨti (Ψi ΛΨti )− Ψi Λ, corresponding to no or maximum variability reduction,
respectively. Here A− is a generalized inverse of A. Another way to gain insight into
the problem is to write the matrix Σi in terms of the signal-to-noise ratio matrix,
Λ/σ2 , as Σi = Λ[I K − Ψti {I Mi + Ψi (Λ/σ2 )Ψti }−1 Ψi (Λ/σ2 )]. Thus, when Λ/σ2 is
close to zero Σi is close to Λ.
To better understand the problem consider the simple example when K = 1 and
ψ(t) = 1 for all t. The functional exposure model (4) becomes Wi (t) = ξi + i (t),
where ξi ∼ N(0, λ) and i (t) ∼ N(0, σ2 ). For simplicity, we denoted by ξi = ξi1 and by
λ = λ1 . This is exactly the classical measurement error model where Wi (t) are viewed
11
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as Mi unbiased proxies of the variable measured with error, ξi , σ2 is the variance of the
measurement error, and λ/(λ + σ2 ) is the reliability of the measurement mechanism.
In this case Σi is a scalar and using the results from equation (9) we obtain

Σi =

λ(σ2 /Mi )
λ
=
≤ min(λ, σ2 /Mi ).
2
λ + σ /Mi
1 + (λ/σ2 )Mi

These expressions reveal the various factors that affect the size of the conditional
variance, Σi , in this simplified context. First, a large number of observations, Mi ,
or a small value of the error variance, σ2 , correspond to a small Σi . Second, a large
σ2 relative to λ, or a small signal-to-noise ratio, λ/σ2 , correspond to Σi ≈ λ. Third,
Σi ≤ σ2 /Mi , which implies that in applications with a large number of observations
per subject the bias induced by using a two-stage procedure might be negligible.
However, applications with small to moderate number of observations per subject,
large measurement error, or small signal-to-noise ratios require special attention.
An important particular case is when the functions are perfectly observed, that
is when σ2 = 0. In this case, if the functional data are single-level, as assumed in
this section, then the two-stage procedure does not induce bias either for the linear
or nonlinear models. This result cannot be generalized to the case when functional
data are observed at multiple levels, as is the case in the SHHS application. Indeed, with the exception of exotic examples, functional data exhibits sizeable withinsubject/between-visit variability, even when the functions are perfectly measured. In
Section 4 we discuss the specific problems induced by two-stage procedures when
functional data has a multi-level structure.
Focusing on Σi as a source of bias in a two-stage procedure provides important
insights, but may also be slightly misleading. Indeed, the bias is more directly affected
by the relative size of β t Σi β and mt (W i )β + Z ti γ than by the absolute size of Σi .

12
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However, the relative size is more complicated to explain and interpret.

3

Bayesian inference

Because of the potential problems associated with two-stage procedures we propose
to use joint modeling. Bayesian inference using Markov Chain Monte Carlo (MCMC)
simulations of the posterior distribution provides a reasonable, robust, and well tested
computational approach for this type of problems. Moreover, Bayesian inference can
easily be extended to the more general models described in Sections 4 and 5. Possible
reasons for the current lack of Bayesian methodology in functional regression analysis
could be: 1) the connection between functional regression models and joint mixed
effects models was not known; and 2) the Bayesian inferential tools were perceived as
unnecessarily complex and hard to implement. We clarified the connection to mixed
effects models in Section 2 and we now show that 2) is not true, thanks to intense
methodological and computational research conducted over the last 10-20 years. See,
for example, the monographs [1, 4, 11, 13] and the citations therein for a good overview
of recent developments.
To be specific, we focus on a Bernoulli/logit outcome model with functional regressors. Other outcome models would be treated similarly. Consider the joint model
with the outcome Yi ∼ Bernoulli(pi ), linear predictor logit(pi ) = ξ ti β + Z ti γ and
functional exposure model Wi (tim ) = ψ tim ξ i + i (tim ). We assume that ξik ∼ N(0, λk )
and i (tim ) ∼ N(0, σ2 ) are a-priori mutually independent for i = 1, . . . , n and m =
1, . . . , Mi . The parameters of the model are Ω = {(ξ i : i = 1, . . . , n), β, γ, Λ, σ2 }.
While i (tij ) are also unknown, we do not incorporate them in the set of parameters
because they are automatically updated by i (tim ) = Wi (tim )−ψ tim ξ i . The prior for ξ i
was already defined and it is standard to assume that the fixed effects parameters, β
and γ, are apriori independent, with β ∼ Normal(0, σβ2 I K ) and γ ∼ Normal(0, σγ2 I P )

13
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where σβ2 and σγ2 are very large and P is the number of Z covariates. In our applications we used σβ2 = σγ2 = 106 , which we recommend when there is no reason to
expect that the components of β and γ could be outside of the interval [−1000, 1000].
In some applications this priors might be inconsistent with the true value of the parameter. In this situations we recommend re-scaling Wi (tim ) and normalizing, or
re-scaling, the Z covariates.
While standard choices of priors for fixed effects parameters exist and are typically
non-controversial, the same is not true for priors of variance components. Indeed,
the estimates of the variance components are known to be sensitive to the prior
specification, see, for example, [6, 10]. In particular, the popular inverse-gamma priors
may induce bias when their parameters are not tuned to the scale of the problem.
This is dangerous in the shrinkage context where the variance components control
the amount of smoothing. However, we find that with reasonable care, the conjugate
gamma priors can be used in practice. Alternatives to gamma priors are discussed by,
for example, [10, 25], and have the advantage of requiring less care in the choice of
the hyperparameters. Nonetheless, exploration of other prior families for functional
regression would be well worthwhile, though beyond the scope of this paper.
We propose to use the following independent inverse gamma priors λk ∼ IG(Ak , Bk ),
k = 1, . . . , K, and σ2 ∼ IG(A , B ), where IG(A, B) is the inverse of a gamma prior
with mean A/B and variance A/B 2 . We first write the full conditional distributions
for all the parameters and than discuss choices of non-informative inverse gamma
parameters. Here we treat λk as parameters to be estimated, but a simpler Empirical
Bayes (EB) method proved to be a reasonable alternative in practice. More precisely,
the EB method estimates λk by diagonalizing the functional covariance operator as
described in Section 2.1. These estimators are than fixed in the joint model. In the
following we present the inferential procedure for the case when λk s are estimated
14
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with obvious simplifications for the EB procedure where they would be fixed.
We use Gibbs sampling [12] to simulate [Ω|D], where D denotes the observed
data. A particularly convenient partition of the parameter space and the associated
full conditional distributions are described below.
P
P
[β, γ|others] ∝ exp[ ni=1 Yi (ξ ti β + Z ti γ) − ni=1 log{1 + exp(ξ ti β + Z ti γ)}]
× exp(−0.5β t β/σβ2 − 0.5γ t γ/σγ2 );
[ξ i |others]

∝ exp[Yi (ξ ti β + Z ti γ) − log{1 + exp(ξ ti β + Z ti γ)}]

[λk |others]

× exp{−0.5||W i − Ψi ξ i ||2 /σ2 − 0.5ξi Λξ i };
P
2
/2 + Bk } ;
∝ IG {n/2 + Ak , ni=1 ξik
P
P
∝ IG{ ni=1 Ti /2 + A , ni=1 ||W i − Ψi ξ i ||2 /2 + B }.

[σ2 |others]

The first two full-conditionals do not have an explicit form, but can be sampled using
Markov Chain Monte Carlo (MCMC). For Bernoulli outcomes the MCMC methodology is routine. We use the Metropolis-Hastings algorithm with a normal proposal
distribution centered at the current value and small variance tuned to provide an acceptance rate around 30-40%. The last two conditionals are explicit and can be easily
sampled. However, understanding the various components of these distributions will
provide insights into rational choices of inverse gamma prior parameters. Indeed, the
first parameter of the full conditional for λk is n/2+Ak , where n is the number of subP
2
jects. Thus, it is safe to choose Ak ≤ 0.01. The second parameter is ni=1 ξik
/2 + Bk ,
P
2
where ni=1 ξik
is an estimator of nλk . Thus, it is safe to choose Bk ≤ 0.01λk . This
discussion is especially relevant for those variance components or, equivalently, eigenvalues of the covariance operator, that are small but estimable. A similar discussion
holds for σ2 and we recommend to choose A ≤ 0.01 and B ≤ 0.01σ2 . Note that
MOM estimators for λk and σ2 are available and reasonable choices of Bk and B are
easy to propose. While we find these rules of thumb useful in practice, they should
15
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be used as any other rule of thumb, cautiously. Moreover, for every application we do
not recommend to rigidly use these prior parameters but rather tune them according
to the general principles described here.

4

Multi-level functional regression models

Multilevel functional data occurs naturally in scientific studies where subject-level
functional data observed at multiple visits are becoming increasingly common. For
example, our research was motivated by the largest collection of sleep EEG data on
an epidemiologic cohort, which contains at each of two visits, quasi-continuous EEG
signals for each subject. We provide two other examples inspired by our current research, but otherwise not covered in this paper. First, magnetic resonance imaging
(MRI) has become commonly used in epidemiological studies and our applications
contain images (e.g., of the brain or heart) at multiple visits. Second, the daily trajectory of blood glucose concentration may provide more information than simple
summaries, such as fasting glucose. These are examples of what we refer to as Multilevel Functional Data (MFD), where functional data are observed at multiple visits.
MFD should not be mistaken for ”functional longitudinal data”, which typically refers
to data containing one function per subject.
This section expands the methodology described in Section 2 to account for the
natural multilevel structure of functional data. Most results in Section 2 generalize
directly to the multilevel case and require mainly notational and computational effort.
However, there are important differences that we are noting here before providing the
technical details below. The most important difference is that the subject-specific
scores have higher variability due to the additional within-level/between-visit variability. This, in turn, leads to larger bias in a two-stage procedure when the outcome
model is not linear. We will address this problem below, after introducing the frame-
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work for multilevel functional regression.

4.1

Joint mixed effects models

The observed data for the ith subject in a Generalized Multilevel Functional Model
(GMFM) is [Yi , Z i , {Wij (tijm ), tijm ∈ [0, 1]}], where Yi is the continuous or discrete
outcome, Z i is a vector of covariates, and Wij (tijm ) is a random curve in L2 [0, 1]
observed at time tijm , which is the mth observation, m = 1, . . . , Mij , for the jth
visit, j = 1, . . . , Ji of the ith subject. We assume that Wij (t) is a proxy observation
of the true underlying subject-specific functional signal Xi (t), and that Wij (t) =
µ(t) + ηj (t) + Xi (t) + Uij (t) + ij (t). Here µ(t) is the overall mean function, ηj (t) is
the visit j specific shift from the overall mean function, Xi (t) is the subject i specific
deviation from the visit specific mean function, and Uij is the residual subject/visit
specific deviation from the subject specific mean. To ensure identifiability we assume
that Xi (t), Uij (t), and ij (t) are uncorrelated and that ij (t) is a white noise process
with variance σ2 . Given the large sample size of the SHHS data, we can assume
that µ(t) and ηj (t) are estimated with negligible error by W̄·· (t) and W̄·j (t) − W̄·· ,
respectively. Here W̄·· (t) is the average over all subjects, i, and visits, j, of Wij (t)
and W̄·j (t) is the average over all subjects, i, of observation at visit j of Wij (t). We
can assume that these estimates have been subtracted from Wij (t), so that Wij (t) =
Xi (t) + Uij (t) + ij (t).
We also assume that the distribution of Yi is in the exponential family with linear predictor ηi and dispersion parameter α, denoted here by EF(ηi , α). The linear
R1
predictor is assumed to have the following form ηi = 0 Xi (t)β(t)dt + Z ti γ, where
(1)

β(·) ∈ L2 [0, 1] is a functional parameter and the main target of inference. If ψk (t)
(2)

and ψl (t) are two orthonormal basis in L2 [0, 1] then Xi (·), Uij (·) have unique rep-
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resentations

Xi (t) =

X
k≥1

(1)

ξik ψk (t), Uij (t) =

X

(2)

ζijl ψl (t); β(t) =

l≥1

X

(1)

βk ψk (t).

(10)

k≥1

Using the same arguments as in Section 2, we use the truncated versions of these
equalities. If K and L are the truncation lags, the multilevel outcome model can be
written as



 Yi ∼ EF(η K , α);
i
P

K
t
 ηiK =
k=1 ξik βk + Z i γ,

(11)

which is identical to the single-level outcome model (3). Other multilevel outcome
models could be considered by including regression terms for the Uij (t) process or,
implicitly, for ζijl . However, we restrict our discussion to models of the type (11).
In this paper we use Multilevel Functional Principal Component Analysis (MFPCA) [7] to obtain the bases that capture most of the functional variability of the
space spanned by Xi (t) and Uij (t), respectively, with the the first few components.
MFPCA is based on the spectral decomposition of the within- and between-visit functional variability covariance operators. We summarize here the main components
of this methodology. Denote by KTW (s, t) = cov{ Wij (s), Wij (t) } and KBW (s, t) =
cov{ Wij (s), Wik (t) } for j 6= k the total and the between covariance operator corresponding to the observed process, Wij (·), respectively. Denote by K X (t, s) =
cov{Xi (t), Xi (s)} the covariance operator of the Xi (·) process and by KTU (t, s) =
cov{ Uij (s), Uij (t) } the total covariance covariance operator of the Uij (·) process.
Note that, by definition, KBU (s, t) = cov{ Uij (s), Uik (t) } = 0 for j 6= k. Moreover,
KBW (s, t) = K X (s, t) and KTW (s, t) = K X (s, t) + KTU (s, t) + σ2 δts , where δts is equal
to 1 when t = s and 0 otherwise. Thus, K X (s, t) can be estimated using a method
b W (s, t). For t 6= s a method of moment
of moments estimator of KBW (s, t), say K
B
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b U (s, t), can be used to estimate K U (s, t). To
estimator of KTW (s, t) − KBW (s, t), say K
T
T
b U (t, t) it was proposed [7] to predict K U (t, t) using a bivariate thin-plate
estimate K
T
T
b U (s, t) for s 6= t. This method was suggested by [31, 34] for
spline smoother of K
T
single-level FPCA and shown to work well in the MFPCA context [7].
Once consistent estimators of K X (s, t) and KTU (s, t) are available, the spectral
decomposition and functional regression proceed as in the single-level case. More
precisely, Mercer’s theorem (see [15], Chapter 4) provides the following convenient
P
(1) (1)
(1)
(1)
(1)
spectral decompositions K X (t, s) = ∞
k=1 λk ψk (t)ψk (s), where λ1 ≥ λ2 ≥ . . .
(1)

are the ordered eigenvalues and ψk (·) are the associated orthonormal eigenfuncP
(2) (2)
(2)
tions of K X (·, ·) in the L2 norm. Similarly, KTU (t, s) = ∞
l=1 λl ψl (t)ψl (s), where
(2)

(2)

(2)

λ1 ≥ λ2 ≥ . . . are the ordered eigenvalues and ψl (·) are the associated orthonormal eigenfunctions of KTU (·, ·) in the L2 norm. The Karhunen-Loève (KL) decompoP
(1)
sition [18, 21] provides the following infinite decompositions Xi (t) = ∞
k=1 ξik ψk (t)
R1
R1
P
(2)
(1)
(2)
ζ
ψ
(t)
where
ξ
=
X
(t)ψ
(t)dt,
ζ
=
Uij (t)ψl (t)dt
and Uij (t) = ∞
ijl
ik
i
ijl
l
k
l=1
0
0
(1)

are the principal component scores with E(ξik ) = E(ζijl ) = 0, Var(ξik ) = λk ,
(2)

Var(ζijl ) = λl . The zero-correlation assumption between the Xi (·) and Uij (·) processes is ensured by the assumption that cov(ξi , ζijl ) = 0. These properties hold for
every i, j, k, and l.
Once the eigenfunctions and the truncation lags K and L are fixed, the model for
observed functional data can be written as a linear mixed model. Indeed, by assuming
a normal shrinkage distribution for scores and errors, the model can be rewritten as


 Wij (t) = PK ξik ψ (1) (t) + PL ζijl ψ (2) (t) + ij (t);
k
k
k=1
l=1
(1)
(2)

 ξik
∼ N(0, λk ); ζijl ∼ N(0, λl ); ij (t) ∼ N(0, σ2 ).
(1)

(2)

(1)

(2)

For simplicity we will refer to ψk (·), ψl (·) and λk , λl

(12)

as the level 1 and 2 eigen-
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functions and eigenvalues, respectively.
We propose to jointly fit the outcome model (11) and the exposure model (12).
Because the joint model is a generalized linear mixed effects model the inferential
arsenal for mixed effects models can be used. In particular, we propose to use a
Bayesian analysis via posterior MCMC simulations. An alternative would be to use a
two-stage analysis by first predicting the scores from model (12) using, for example,
BLUP and then plug-in these estimates into model (11).
While the parallels between single-level and multilevel functional regression are
obvious our presentation is far from being unnecessarily repetitive. Indeed, close
inspection of exposure models (4) and (12) will reveal differences with important
consequences. The most important difference is that model (12) contains the term
PL
(2)
l=1 ζijl ψl (t) which quantifies the visit/subject-specific deviations from the subject
specific mean. This variability is typically large and makes estimation of the subjectspecific scores, ξ i , difficult even when the functions are perfectly observed, that is
σ2 = 0. Thus, the effects of variability on bias in a two-stage procedure will typically
be more severe in a multilevel context, especially when the within-subject variability
is large compared to the between-subject variability. In the next section we provide
the technical details associated with a two stage procedure and provide a simple
example to build up the intuition.

4.2

Posterior distribution of subject-specific functional scores

We now turn our attention to calculating the posterior distribution of subject-specific
scores for the MFPCA model (12). While this section is more technical and contains some pretty heavy notation, the results are important because they form the
basis of any reasonable inferential procedure in this context, be it two-stage or
joint modeling.

We first introduce some notation for a subject i.

Let Wij =
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{Wij (tij1 ), . . . , Wij (tijMij )}t be the Mij × 1 vector of observations at visit j, Wi =
Pi
t
t
, . . . , WiJ
)t be the ( Jj=1
Mij ) × 1 vector of observations obtained by stacking
(Wi1
i
(1)

(1)

(1)

W ij , ψ ij,k = {ψk (tij1 ), . . . , ψk (tijMij )}t be the Mij × 1 dimensional vector corre(1)

(1)t

(1)t

sponding to the kth level 1 eigenfunction at visit j, and ψ ik = {ψ i1,k , . . . , ψ iJi ,k }t be
Pi
the ( Jj=1
Mij ) × 1 dimensional vector corresponding to the kth level 1 eigenfunction
(1)

(1)

(1)

at all visits. Also, let Ψij = {ψ ij,1 , . . . , ψ ij,K } be the Mij × K dimensional matrix
(1)

of level 1 eigenvectors obtained by binding the column vectors ψ ij,k corresponding to
Pi
(1)
(1)
(1)
the jth visit and Ψi = (ψ i1 , . . . , ψ iK ) be the ( Jj=1
Mij ) × K dimensional matrix
(1)

of level 1 eigenfunctions obtained by binding the column vectors ψ i1 . Similarly, we
(2)

(2)

(2)

(2)

(1)

(1)

define the vectors ψ ijl , ψ il , Ψij and Ψi . Finally, let Λ(1) = diag{λ1 , . . . , λK }
(2)

(2)

and Λ(2) = diag{λ1 , . . . , λL } be the K ×K and L×L dimensional diagonal matrices
of level 1 and level 2 eigenvalues, respectively.
As in the single level case, [ξ i |W i ] = Normal{m(W i ), Σi }, where m(W i ) and
Σi have a more complex structure. Indeed, if ΣWi denotes the covariance matrix of
(1)t

W i then m(W i ) = Λ(1) Ψi

(1)t

(1)
Σ−1
− Λ(1) Ψi
Wi Wi and Σi = Λ

(1)

(1)
Σ−1
Wi Ψi Λ .

It can be shown that ΣWi is a matrix with the (j, j 0 )th block matrix equal to Bi,jj 0
(1)

(2)

(1)t

(2)t

(1)
t
Ψij 0 if j 6= j 0 and Bi,jj = σ2 I Mij + Ψij Λ(2) Ψij +
where Bi,jj 0 = Bi,j
0 j = Ψij Λ
(1)

(1)t

Ψij Λ(1) Ψij

for 1 ≤ j, j 0 ≤ Ji .

Theorem 1 Consider the multilevel functional exposure model (12) with a fixed number of observations per visit, i.e. Mij = Mi , at the same subject-specific times for
(1)

(1)t

each visit, i.e. tijm = tim for all j = 1, . . . , Ji . Denote by K X = Ψi1 Λ(1) Ψi1 , by
(2)

(2)t

KTU = Ψi1 Λ(2) Ψi1 , by 1Ji ×Ji the Ji × Ji dimensional matrix of ones, and by ⊗ the
Kronecker product of matrices. Then ΣWi = 1Ji ×Ji ⊗ K X + I Ji ⊗ (σ2 I Mi + KTU ) and
2
U −1
2
U −1
Σ−1
K X (Ji K X +σ2 I Mi +KTU )−1 }.
Wi = I Ji ⊗(σ I Mi +KT ) −1Ji ×Ji ⊗{(σ I Mi +KT )

Theorem 2 Assume the balanced design considered in Theorem 1 and denote by
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W̄ i =

PJi

j=1

(1)t

W ij /Ji . Then m(W i ) = Λ(1) Ψi1 {K X +
(1)t

Σi = Λ(1) − Λ(1) Ψi1 {K X +

1
(σ2 I Mi
Ji

1
(σ2 I Mi
Ji

+ KTU )}−1 W̄ i and

(1)

+ KTU )}−1 Ψi1 Λ(1) .

See the Appendix for proofs.
Theorem 2 provides a particularly simple description of the conditional distribution ξ i |W i . Moreover, it shows that, conditional on the smoothing matrices Λ(1) and
Λ(2) , the conditional distribution ξ i |W i is the same as the conditional distribution
ξ i |W̄ i . We now provide a simple example where all calculations can be done explicitly
to illustrate the contribution of each individual source of variability to the variability
of the posterior distribution ξ i |W i , Σi . As described in section 2.2, this variability
affects the size of the estimation bias in a two-stage procedure. Thus, it is important
to understand in what applications this might be a problem.
Consider a balanced design model with K = L = 1 and ψ (1) (t) = 1, ψ (2) (t) = 1
for all t. The exposure model becomes a balanced mixed two-way ANOVA model


 Wij (t) = ξi + ζij + ij (t);

 ξi
∼ N(0, λ1 ); ζij ∼ N(0, λ2 ); ij (t) ∼ N(0, σ2 ),
(1)

(13)

(2)

where, for simplicity, we denoted by ξi = ξi1 , ζij = ζij1 , λ1 = λ1 and by λ2 = λ1 . In
this case the conditional variance Σi is a scalar and, using the results from Theorem 2,
we obtain Σi =

λ1 {λ2 /Ji +σ2 /(Mi Ji )}
λ1 +{λ2 /Ji +σ2 /(Mi Ji )}

≤ min{λ1 , λ2 /Ji + σ2 /(Mi Ji )}. Several important

characteristics of this formula have direct practical consequences. First, the withinsubject/between-visit variability, λ2 , is divided by the number of visits, Ji . In many
applications λ2 is large compared to λ1 and Ji is small, leading to a large variance Σi .
For example, in the SHHS study Ji = 2 and the functional analog of λ2 is roughly 4
times larger than the functional analog of λ1 . Second, in contrast to the single-level
case, even when functions are perfectly observed, that is σ2 = 0, the variance Σi is not
22
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zero. Third, in many applications σ2 /(Mi Ji ) is negligeable because the total number
of observations for subject i, Mi Ji , is large. For example, in the SHHS, Mi Ji ≈ 1600.

5

Generalizing the functional regression model

We have shown that single- and multilevel functional regression models can be viewed
as mixed effects models. Thus, the inferential machinery developed for mixed effects
models can be applied to complex functional regression settings with only minimal
changes. Another important consequence is that the mixed effects framework provides
a natural and modular framework for generalization. Indeed, mixed effects regression
modules developed for other problems can easily be incorporated with the methodology described here. For example, consider the case when an additional covariate,
say d, in the linear predictor equation (3) has a smooth effect on the outcome. More
P
t
precisely, the linear predictor has the form ηiK = K
m=1 ξik βk + Z i γ + f (di ), where
f (·) is unspecified. Using, for example, penalized splines regression [29] the function
P
f (·) can be parameterized as f (d1i ) = α0 + α1 di + . . . + αp dpi + Ll=1 al (di − κl )p+ ,
where al ∼ N(0, σa2 ), p is the degree of the spline, κl , l = 1, . . . , L are fixed knots, and
xp+ = xp if x > 0 and 0 otherwise. Thus, the outcome model remains a mixed effects
model by simply viewing α0 , . . . , αp as fixed effects and al , l = 1, . . . , L as random
effects parameters. Extensions to multiple uni- or multivariate smooth functions is
similar and will not be described here in detail. Such extensions are neither exotic
nor rare. For example, in the SHHS the outcome, Yi , could be the Chronic Heart
Disease (CHD) indicator, the functional regressors, Wij (·), could be the normalized
sleep EEG δ-power, and d could be age or body mass index (BMI) or both.
A different type of generalization occurs when the outcome observations are clustered. For example, consider the case when one observes the outcome Yij for a subject i at visit j. A standard approach to account for correlation is to add a visit-
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specific random intercept. More precisely, the linear predictor of the outcome model
is ηijK = ri + ηijK , where ri ∼ Normal(0, σv2 ) are visit-specific random intercepts and
ηijK is the linear predictor with a structure as in (3). Thus, as with adding smooth
functions, adding random intercepts is equivalent to adding a layer of random effects
that control the shrinkage of the cluster means or, equivalently, the correlation among
same-cluster observations. Other, more complex, random effects structures may also
be added using similar constructions.

6

Simulation studies

In this section, we compare the performance of the joint analysis procedure with the
two-stage procedure through simulation studies. We examine the Bernoulli model
with probit link when the functional exposure model is single-level, as in Section 2,
and multilevel, as in Section 4.
The outcome data was simulated from a Bernoulli/probit model with linear preR1
dictor Φ−1 (pi ) = β0 + 0 Xi (t)β(t) dt + zi γ, for i = 1, . . . , n, where n = 1000 is
the number of subjects. We used the functional predictor Xi (t) = ξi ψ1 (t), where
ξi ∼ N (0, λ1 ) and ψ1 (t) ≡ 1, evaluated at M = 15 equidistant time points in [0, 1].
We set β0 = 1, γ = 1 and a constant functional parameter β(t) ≡ β. The zi s are
taken equally spaced between [−1, 1] with z1 = −1 and zn = 1. Note that the linear
predictor can be re-written as Φ−1 (pi ) = β0 + βξi + zi γ. In the following subsections
we conduct simulations with different choices of β and type of functional exposure
model. All models are fit using joint Bayesian inference via MCMC posterior simulations and a two-stage approach using either BLUP or numerical integration [23]. We
simulated N = 100 data sets from each model.
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6.1

Single-level functional exposure model

Consider the case when for each subject, i, instead of observing Xi (t), one observes
the noisy predictors Wi (t), where Wi (t) = Xi (t) + i (t), i = 1, . . . , n and i (tm ) ∼
Normal(0, σ2 ) is the measurement error. We set λ1 = 1, consider three values of the
signal β = 0.5, 1.0, 1.5 and three different magnitudes of noise σ = 0 (no noise),
σ = 1 (moderate) and σ = 3 (very large). Figure 8 shows the boxplots of the
parameter estimates β̂ and γ̂. The top and bottom panels provide results for the
joint Bayesian analysis and the two-stage analysis with BLUP, respectively. The left
and middle panels display the parameter estimates for different magnitudes of noise
and the right panel presents the bias of the estimates of β for several true values
of β. For the two-stage procedure when the amount of noise, σ , or the absolute
value of the true parameter, |β|, increases, the bias increases. These results confirm
our theoretical discussion in Section 2 and indicate that bias is a problem both for
the parameters of the functional variables measured with error and of the perfectly
observed covariates. Moreover, bias increases when the true functional effect increases
as well as when measurement error increases.
For the case σ = 3, Table 1 displays the root mean squared error (RMSE) and
coverage probability of confidence intervals for β and γ. The two-stage approach with
scores estimated by numerical integration has a much higher RMSE than the other
two methods, which have a practically equal RMSE. However, it would be misleading
to simply compare the RMSE for the joint Bayesian inference and the two-stage
procedure based on BLUP estimation. Indeed, the coverage probability for the latter
procedure is far from the nominal level and can even drop to zero. This is an example
of good RMSE obtained by a combination of two wrong reasons: the point estimate
is biased and the variance is underestimated.
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Method

β̂

β

γ̂

RMSE

80%CI cov.

50%CI cov.

RMSE

80%CI cov.

50%CI cov.

0.5

0.20

0.00

0.00

0.10

0.79

0.46

Numerical

1.0

0.46

0.00

0.00

0.17

0.41

0.09

integration

1.5

0.81

0.00

0.00

0.27

0.03

0.00

0.5

0.06

0.84

0.56

0.10

0.79

0.46

1.0

0.16

0.26

0.11

0.17

0.41

0.09

1.5

0.40

0.01

0.00

0.27

0.03

0.00

0.5

0.07

0.85

0.58

0.11

0.77

0.54

1.0

0.14

0.83

0.48

0.14

0.80

0.52

1.5

0.39

0.85

0.51

0.23

0.86

0.49

BLUP

Bayesian

Table 1: The comparison between the two-stage estimates (with numerical integration
or BLUP) and Bayesian estimates of β and γ with respect to root mean squared error
(RMSE), and coverage probability of the 80% and 50% confidence intervals (80%CI
cov. and 50%CI cov.) for σ = 3.

6.2

Multilevel functional exposure model

Consider now the situation when the predictors are measured through a hierarchical
functional design, as in SHHS. To mimic the design of the SHHS, we assume J = 2
visits per subject and that the observed noisy predictors Wij (t) are generated from
the model Wij (t) = Xi (t) + Uij (t) + ij (t), for each subject i = 1, . . . , n and visit j =
1, . . . , J, where ij (t) ∼ Normal(0, σ2 ) and Uij (t) = ζij ψ2 (t) with ζij ∼ Normal(0, λ2 ),
ψ2 (t) ≡ 1. We used various choices of λ1 , λ2 and σ2 , and compared the two-stage
analysis with the scores estimated by BLUP with a joint Bayesian analysis. As in
the single-level case, the bias depends on the factor 1 + β 2 Σi and the only technical
difference is the calculation of Σi . Thus, we limit our analyses to the case β = 1 and
examine the effects of the other factors that may influence estimation.
Figure 2 presents the boxplots of the estimates of β using the joint Bayesian
analysis (top panels) and the two-stage method with BLUP estimation of scores
(bottom panels). The left panels correspond to λ1 = 1, λ2 = 1 and three values of σ ,
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0.5, 1 and 3. The joint Bayesian inference produces unbiased estimates, while the twostage procedure produces biased estimates with the bias increasing only slightly with
the measurement error variance. This confirms our theoretical results that indicated
that, typically, in the hierarchical setting the noise magnitude is not the main source
of bias. The middle and right panels display results when the measurement error
variance is fixed, σ = 1. The middle panels show results for the case when the
between-subject variance is small, λ1 = 0.1, and three values of the within-subject
variance, λ2 = 0.1, 0.4 and 0.8. The right panels show results for the case when
the between-subject variance is large, λ1 = 3, and three values of the within-subject
variance, λ2 = 1, 3 and 5. These results confirm our theoretical analyses in Section
4. Indeed, bias is small when the between-subject variability, λ1 , even when the
within subject variability, λ2 , is much larger relative to λ1 . When λ1 is large then
bias is much larger and increases with λ2 . In contrast, the joint Bayesian analysis
produces unbiased estimators with variability increasing with λ2 . The RMSE and
coverage probability results were similar to the ones for the single-level case. We have
also obtained similar results for γ. While these results are not reported here they are
available upon request and can be reproduced using the attached simulation software.
In spite of the obvious advantages of the joint Bayesian analysis, the message is
more nuanced than simply recommending this method. In practice, the two-stage
method with BLUP estimation of scores is a robust alternative that often produces
similar results to the joint analysis with less computational effort. Our recommendation is to apply both methods and compare their results. We also provided insight
into why and when inferential differences may be observed, and, especially, how to
address such differences.
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7

The analysis of sleep data from the SHHS

We now apply our proposed methods to the SHHS data. We considered 3, 201 subjects
with complete baseline and visit 2 data with sleep duration that exceeds 4 hours at
both visits and we analyzed data for the first 4 hours of sleep. We focus on the
association between hypertension (HTN) and sleep EEG δ-power spectrum. Complete
descriptions of the SHHS data set and of this functional regression problem can be
found in [5, 7]. We provide here a short summary.
A quasi-continuous EEG signal was recorded during sleep for each subject at two
visits, roughly 5 years apart. This signal was processed using the Discrete Fourier
Transform (DFT). More precisely, if x0 , . . . , xN −1 are the N measurements from a
P −1
−2πink/N
, k = 0, . . . , N − 1, where
raw EEG signal then the DFT is Fx,k = N
n=0 xn e
√
i = −1. If W denotes a range of frequencies, then the power of the signal in
P
2
that frequency range is defined as PW = k∈W Fx,k
. Four frequency bands were of
particular interest: 1) δ [0.8-4.0Hz]; 2) θ [4.1-8.0Hz]; 3) α [8.1-13.0Hz]; 4) β [13.120.0Hz]. These bands are standard representations of low (δ) to high (β) frequency
neuronal activity. The normalized power in the δ band is NPδ = Pδ /(Pδ +Pθ +Pα +Pβ ).
Because of the nonstationary nature of the EEG signal the DTF and normalization
are applied in adjacent 30 second intervals resulting in the function of time t →
NPδ (t), where t indicates the time corresponding to a particular 30 second interval.
To illustrate this, the dots in Figure 3 are the pairs {t, NPδ (t)} while the solid lines
represent the estimated mean function using penalized splines. Our goal is to regress
HTN on the subject-specific functional characteristics that do not depend on random
or visit-specific fluctuations.
The first step was to subtract from each observed normalized function the corresponding visit-specific population average. Following notations in Section 4.2, Wij (t)
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denotes these “centered” functional data for subject i at visit j during the tth 30second interval. We used model (12) as the exposure model where the subject-level
P
(1)
function, K
k=1 ξik ψk (t), is the actual functional predictor used for HTN.
To obtain the subject- and visit-level eigenfunctions and eigenvalues we used the
MFPCA methodology introduced by [7] and summarized in section 4.1. Table 2
provides the estimated eigenvalues at both levels indicating that Level 1 variability,
associated with subject-level variability, is practically explained by the first three
dimensions. For example, the first eigenvalue explains 80.6% of the variation, while
the second and third eigenvalues explain 7.7% and 3.7% of variation, respectively.
Together, they explain more than 91% of the subject level variation. Figure 4 provides
the graphical representation of subject-level variability. The top-left plot displays
the average over all subjects and visits as well as the visit specific averages of the
normalized sleep δ-power. The other three panels display the first three subject-level
eigenfunctions. The first eigenfunction is positive and roughly constant, indicating
that subjects with positive scores on this component will tend to get a consistently
larger proportion of sleep EEG δ-power than the population average.
Table 2 indicates that there are more directions of variation in the Level 2 functional space, associated with visit deviations from the subject-specific means. Indeed,
90% of the variability is explained by the first 14 principal components with 50% of the
variability being explained by the first 4 components. The proportion of variability
explained by subject-level functional clustering was ρ̂W = 0.213 (95% confidence interval: 0.210, 0.236), i.e, 21.3% of variability in the sleep EEG δ-power is attributable
to the subject-level variability.
We considered the following model logit{P (Yi = 1)} = β0 +

PK

k=1

βk ξik + ZiT ,

where Yi is the HTN indicator variable, K = 3, ξik is the score of subject i on the kth
(1)

subject specific eigenfunction, ψk (t), and Zi is a vector of other covariates. Table 3
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Level 1 eigenvalues
Component
1
2
3
−3
eigenvalue (×10 ) 13.00
1.24
0.55
% var
80.59
7.68
3.38
cumm. % var
80.59 88.27 91.66
Level 2 eigenvalues
Component
1
2
3
4
5
6
7
eigenvalue (×10−3 ) 12.98
7.60
7.46
6.45
5.70
4.47
3.07
% var
21.84 12.79 12.55 10.85
9.58
7.52
5.17
cumm. % var
21.84 34.63 47.17 58.02 67.61 75.13 80.30
Table 2: Estimated eigenvalues on both levels for SHHS data. We showed the first 3
components for level 1 (subject level), and 7 components for level 2.

provides results for two models, one without confounding adjustment (labeled Model
1) and one with confounding adjustment (labeled Model 2). The confounders in Model
2 are sex, smoking status (with three categories: never smokers, former smokers, and
current smokers), age, body mass index (BMI) and respiratory disturbance index
(RDI). Each model was fitted using a two-stage analysis with BLUP estimates of
scores from the exposure model and a joint Bayesian analysis.
Using a two-stage analysis, both models indicated that the first principal component score is strongly and negatively associated with hypertension. The magnitude of
association varies with the amount of confounding adjustment. For example, Model
1 estimates that a subject with one unit increase in the first principal component has
e−1.58 = 0.204 (p value: < 0.001) times the odds of HTN. Considering the scale of the
principal component scores (the first principal component scores have mean zero and
standard deviation 0.11), standardized coefficients would be easier to interpret. After
standardizing, one standard deviation increase in the first principal component score
is associated with an odds ratio e−0.205 = 0.815 (p value: < 0.001). Model 2, which
adjusts for all the confounders, estimated an odds ratio of e−0.86 = 0.423 per unit increase in the first principal component score, or an odds ratio e−0.11 = 0.895 per one
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standard deviation increase in the first principal component score. The second and
third principal components were not found to be associated with hypertension. The
negative relationship between smoking and hypertension may seem counterintuitive.
However, in this study smokers are younger, have a lower body mass index and many
other smokers with severe disease were not included in the study [35].
The point estimators and scientific findings are similar for the two methods, while
the joint Bayesian analysis produces wider confidence intervals. Given the results
in this paper, these results are easy to explain. As in our simulation example in
Section 6.2, the between-subject variability is relatively small and bias is minimal
in spite of the much larger within-subject variability. However, the joint Bayesian
analysis correctly incorporates the variability that the two-stage procedure ignores
and produces wider confidence intervals.
It is important to note that the joint Bayesian analysis is simple, robust and
requires only minimal tunning. This is possible because of our MFPCA method,
which produces a parsimonious decomposition of the functional variability using orthonormal bases. The effect of using orthonormal bases is to reduce the posterior
correlation of corresponding parameters, which leads to excellent mixing properties
and stable inference. For example, Figure 5 displays chains for regression coefficients
of the principal component scores for Model 1 and the corresponding autocorrelation
functions. The lack of correlation and fast convergence to the target distribution is
very encouraging. Thus, we recommend the joint Bayesian analysis as a practical,
not only theoretically appealing, approach to inference in this context.

8

Discussion

The methodology introduced in this paper was motivated by many current studies
where exposure or covariates are functional data collected at multiple time points.
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score 1
score 2
score 3
sex
smk:former
smk:current
age
BMI
RDI

Two-stage
Model 1
-1.58 (0.28)*
0.66 (0.97)
1.74 (1.56)

analysis
Joint analysis
Model 2
Model 1
Model 2
-0.86 (0.30)* -1.56 (0.36)* -0.77 (0.35)*
-0.26 (1.04)
0.54 (1.74)
-2.94 (1.35)*
-0.26 (1.67)
3.82 (2.03)
-0.20 (3.39)
0.10 (0.08)
0.12 (0.08)
-0.19 (0.08)*
-0.19 (0.08)*
-0.11 (0.13)
-0.10 (0.13)
0.06 (0.00)*
0.07 (0.00)*
0.06 (0.01)*
0.06 (0.01)*
0.01 (0.00)*
0.01 (0.00)*

Table 3: Models for association between hypertension and sleep EEG δ-power.
Smoking status has three categories: never smokers (reference), former smokers
(smk:former) and current smokers (smk.current). For the variable sex, female is
the reference group and an asterisks indicates significance at level 0.05.

The SHHS is just one example of such studies. The GMFLM methodology provides
a self contained set of statistical tools that is robust, fast and reasonable for such
studies. These properties are due to: 1) the connection between GMFLMs and mixed
effects models; 2) the parsimonious decomposition of functional variability in principal
directions of variation; 3) the modular way mixed effects models can incorporate
desirable generalizations; and 4) the good properties of Bayesian posterior simulations
due to the orthogonality of the directions of variation.
The methods described in this paper have a few limitations. First, they require
a large initial investment in developing and understanding the multilevel functional
structure. Second, they require many choices including number and type of basis
functions, distribution of random effects, method of inference, etc. The choices we
made are reasonable, but other choices may be more appropriate in other applications.
Third, the computational problems may seem daunting, especially when we propose
a joint Bayesian analysis of a data set with thousands of subjects, multiple visits and
thousands of random effects. However, we do not think that this is a real problem,

32
http://biostats.bepress.com/jhubiostat/paper173

and to address this issue we posted the software we developed for our simulations in
Section 6 at www.biostat.jhsph.edu/~ccrainic/webpage/software/GFR.zip.

Appendix
(1)

Proof of Theorem 1. In a balanced design, the Mi -dimensional vector ψ ij,k does not depend
(1)

on j. Thus, the Mi Ji -dimensional vector corresponding to the level 1 eigenfunction ψk can be
(i)
(1)
written as ψ ik = 1Ji ⊗ ψ i1,k , where 1Ji is the Ji -dimensional vector of ones. It follows that the
(1)

(1)

(1)

(1)t

matrix Ψij = Ψi1 for all 1 ≤ j ≤ Ji . Moreover, Bi,jj 0 = Ψi1 Λ(1) Ψi1

= K X for j 6= j 0 and

(2)
(2)t
(1)
(1)t
σ2 I Mi + Ψi1 Λ(2) Ψi1 + Ψi1 Λ(1) Ψi1
X

Bi,jj =
= σ2 I Mi + KTU + K X . For simplicity, the dependence
U
of KT and K on i has been suppressed. Thus, ΣWi = 1Ji ×Ji ⊗ KTX + I Ji ⊗ (σ2 I Mi + KTU ). It is
−1
−1
enough to show that ΣWi Σ−1
Wi = ΣWi ΣWi = I Mi Ji , where ΣWi is given in Theorem 1. We only
−1
prove that ΣWi ΣWi = IMi Ji since the proof of the second equality is analogous.
For simplicity of presentation, denote by D = σ2 I Mi + KTU and C = K X . Also, ΣWi =
1Ji ×Ji ⊗ C + I Ji ⊗ D. Thus, ΣWi Σ−1
Wi is equal to
I Mi Ji + 1Ji ×Ji ⊗ {CD−1 − Ji CD−1 C (D + Ji C)−1 − C(D + Ji C)−1 }.
It is enough to show that CD−1 − Ji CD−1 C (D + Ji C)−1 − C(D + Ji C)−1 = 0. This equality holds
because Ji CD−1 C (D + Ji C)−1 = CD−1 (D + Ji C − D) (D + Ji C)−1 = CD−1 − C(D + Ji C)−1 .
Proof of Theorem 2. We use the same notations as in Theorem 1. For balanced designs
(1)
(1)
(1)
(1)
(i)
(1)
(1)
ψ ij,k = ψ i1,k for 1 ≤ j ≤ Ji . Hence, Ψi = 1Ji ⊗ Ψi1 as ψ ik = 1Ji ⊗ ψ i1,k and Ψi1 =
(1)

(1)

(ψ i1,1 , . . . , ψ i1,K ). Thus, m(W i ) is
o 
n


(1)t
I Ji ⊗ D−1 − 1Ji ×Ji ⊗ D−1 C(D + Ji C)−1 W i
= Λ(1) 1TJi ⊗ Ψi1
i
h
(1)t
(1)t
= Λ(1) 1TJi ⊗ {Ψi1 D−1 } − Ji 1TJi ⊗ {Ψi1 D−1 C(D + Ji C)−1 } W i
i
h
(1)t
= Λ(1) 1TJi ⊗ {Ψi1 (D + Ji C)−1 } W i
PJi
(1)t
= Λ(1) j=1
{Ψi1 (D + Ji C)−1 }W ij
(1) (1)t
= Λ Ψi1 (Ji−1 D + C)−1 W̄ i ,
PJi
(1)t
where W̄ i = j=1
W ij /Ji is the mean vector of W ij ’s. We used the fact that Ψi1 (Ji−1 D + C)−1
does not vary with j. Using a similar technique, Σi is
(1)t

(1)

(1)
T
−1
−1
−1
= Λ(1) − Λ(1) {1
h Ji ⊗ Ψi1 } [I Ji ⊗ D − i1Jni ×Ji ⊗ {D oC(D + Ji C) }] {1Ji ⊗ Ψi1 }Λ
(1)t

= Λ(1) − Λ(1) 1TJi ⊗ {Ψi1 (D + Ji C)−1 }
(1)t

(1)

1Ji ⊗ Ψi1

Λ(1)

(1)

= Λ(1) − Ji Λ(1) Ψi1 (D + Ji C)−1 Ψi1 Λ(1) .

References
[1] B.P. Carlin and T.A. Louis. Bayes and Empirical Bayes Methods for Data Analysis, Second
Edition. Chapman & Hall/CRC, 2000.
[2] R.J. Carroll, D. Ruppert, L.A. Stefanski, and C.M. Crainiceanu. Measurement Error in Nonlinear Models: A Modern Perspective. Chapman & Hall/CRC, New York, 2006.

33
Hosted by The Berkeley Electronic Press

σǫ = 3

β = 1

Bias(β̂)

0.8
1

3

0

1

3

0.5

1.0

σǫ

σǫ

β

β = 1

β = 1

σǫ = 3

1.5

Bias(β̂)

0.8
0

1

3

−0.5

0.6

0.6

0.8

0.0

0.5

1.4
1.2

γ̂

1.0

β̂

1.0

1.2

1.4

1.0

0

−0.5

0.6

0.6

0.8

0.0

0.5

1.4
1.2

γ̂

1.0

β̂

1.0

1.2

1.4

1.0

β = 1

0

1

σǫ

3

0.5

σǫ

1.0

1.5

β

Figure 1: Joint Bayesian analysis (upper panel) versus two-stage analysis with BLUP
(bottom panel): box plots of β̂ and γ̂ for different values of β and σ .
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Figure 3: The EEG signal series for three subjects at both visits. The horizonal axis
is time in hours, and the vertical axis is the percentage of delta power sleep in 30
seconds windows. Each subject was measured at both visit 1 and visit 2. The solid
lines are smooth estimates of the mean functions.
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Figure 4: Characteristics of normalized sleep EEG δ-power. Top-left panel: overall
mean (solid line), baseline mean (dashed line) and visit 2 mean (dotted line). Other
three panels: First three eigenvalues of the subject specific deviations from the visit
mean function.
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